Overview

Eltrombopag Induced Liver Dysfunction During Treatment of Immunethrombocytopenic Purpura

Status:
RECRUITING
Trial end date:
2026-01-20
Target enrollment:
Participant gender:
Summary
this study amis to assess the incidence and severity of liver dysfunction in ITP patients receiving eltrombopag.
Phase:
NA
Details
Lead Sponsor:
Sohag University
Treatments:
eltrombopag